Clinical Trial Update: An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia [Phase 1, Phase 2]

View source ↗

Summary

An open-label Phase 1/2 clinical trial of retinal gene therapy for choroideremia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia

Snippet

Sponsor: University of Alberta | Conditions: Choroideremia | Phase 1, Phase 2 | Status: COMPLETED